Radiopharm Theranostics Limited (AU:RAD) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Radiopharm Theranostics Limited announced the cessation of 13,680,012 restricted options that expired on November 25, 2024, without exercise or conversion. This development may interest investors watching the company’s capital management strategies and stock performance. Keep an eye on how this could influence Radiopharm’s market dynamics.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.